Literature DB >> 15555023

Grey lungs and blue moods: smoking cessation in the context of lifetime depression history.

Kay Wilhelm1, Karen Arnold, Heather Niven, Robyn Richmond.   

Abstract

OBJECTIVE: To present an overview of the relationship between depression and cigarette smoking and to provide recommendations for clinicians who wish to help patients with a history of depression to stop smoking.
METHOD: English language journal articles published in the last 15 years on clinical material related to depression history, smoking cessation and related health issues were collected via MEDLINE, PsycINFO and Cochrane Library database searches.
RESULTS: Nicotine dependence is associated with increased rates of depression prior to and after taking up smoking as well as increased rates of suicidal ideation. Depression history is associated with increased rates of nicotine dependence, problems with smoking cessation and depression after cessation. While nicotine replacement and counselling are effective for smoking cessation, standard smoking cessation strategies may not pay sufficient attention to the needs of smokers with a depression history. Some antidepressants (bupropion and nortriptyline) are particularly effective for those with a lifetime depression history as they appear to assist with dysphoria during withdrawal and prevent relapse. Psychological and lifestyle strategies, such as motivational interviewing, relaxation exercises and mood charts, assist in mood regulation over and above the standard smoking cessation treatments for smokers with a depression history, who require more attention to relapse of depression and smoking after quitting.
CONCLUSIONS: There is a complex and circular relationship between depression, smoking and medical illness that complicates smoking cessation in those who have a history of depression. Depression-history smokers require a multimodal approach to assist with mood regulation and nicotine withdrawal. Further research is required to identify effective strategies to reduce smoking in this context.

Entities:  

Mesh:

Year:  2004        PMID: 15555023     DOI: 10.1080/j.1440-1614.2004.01489.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  7 in total

1.  Smoking cessation in patients with psychiatric disorders.

Authors:  Alan J Gelenberg; Jose de Leon; A Eden Evins; Joseph J Parks; Nancy A Rigotti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Depression, Neuroticism, and Mood-Regulation Expectancies for Engagement and Disengagement Coping Among Cigarette Smokers.

Authors:  Dara G Friedman-Wheeler; David A F Haaga; Kathleen C Gunthert; Anthony H Ahrens; Elizabeth McIntosh
Journal:  Cognit Ther Res       Date:  2008

Review 3.  Past major depression and smoking cessation outcome: a systematic review and meta-analysis update.

Authors:  Brian Hitsman; George D Papandonatos; Dennis E McChargue; Andrew DeMott; María José Herrera; Bonnie Spring; Belinda Borrelli; Raymond Niaura
Journal:  Addiction       Date:  2013-02       Impact factor: 6.526

4.  Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease.

Authors:  Rebecca E Schane; Louise C Walter; Alexis Dinno; Ken E Covinsky; Prescott G Woodruff
Journal:  J Gen Intern Med       Date:  2008-08-09       Impact factor: 5.128

5.  Varenicline augmentation in depressed smokers: an 8-week, open-label study.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Laura B Whiteley; Lawrence H Price
Journal:  J Clin Psychiatry       Date:  2009-03-24       Impact factor: 4.384

Review 6.  Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes.

Authors:  Len Fromer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-11-21

7.  A randomized controlled trial of a smoking cessation intervention conducted among prisoners.

Authors:  Robyn Richmond; Devon Indig; Tony Butler; Kay Wilhelm; Vicki Archer; Alex Wodak
Journal:  Addiction       Date:  2013-03-11       Impact factor: 6.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.